Produtos naturais como candidatos a fármacos úteis no tratamento do mal de Alzheimer


Autoria(s): Viegas Jr., Cláudio; Bolzani, Vanderlan da Silva; Furlan, Maysa; Manssour Fraga, Carlos Alberto; Barreiro, Eliezer J.
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

27/05/2014

27/05/2014

01/07/2004

Resumo

Alzheimer's disease (AD) is a progressive neurodegenerative pathology with severe economic and social impact. There is currently no cure, although cholinesterase inhibitors provide effective temporary relief of symptoms in some patients. Nowadays drug research and development are based on the cholinergic hypothesis that supports the cognition improvement by regulation of the synthesis and release of acetylcholine in the brain. There are only four commercial medicines approved for treatment of AD and natural products have played an important role in the research for new acetylcholinesterase inhibitors.

Formato

655-660

Identificador

http://dx.doi.org/10.1590/S0100-40422004000400021

Quimica Nova, v. 27, n. 4, p. 655-660, 2004.

0100-4042

http://hdl.handle.net/11449/67779

10.1590/S0100-40422004000400021

S0100-40422004000400021

WOS:000223108900021

2-s2.0-15044356788

2-s2.0-15044356788.pdf

Idioma(s)

por

Relação

Química Nova

Direitos

openAccess

Palavras-Chave #Acetylcholinesterase #Alzheimer's disease #Natural products #11 hydroxygalantamine #9 o norgalantamine #acetylcholine #cholinesterase inhibitor #donepezil #galantamine #Ginkgo biloba extract #natural product #rivastigmine #tacrine #unclassified drug #acetylcholine release #Alzheimer disease #brain function #cholinergic activity #cognition #conference paper #degenerative disease #drug efficacy #drug indication #drug synthesis #economic aspect #hypothesis #neuropathology #regulatory mechanism #social aspect
Tipo

info:eu-repo/semantics/conferencePaper